G protein-coupled receptors (GPCRs) are one of the most popular target classes investigated in the drug-discovery process. With its selection of kits (cAMP femto, cAMP dynamic and cAMP HiRange), Cisbio allows detection of a broad range of cyclic AMP concentrations.
(IP3). cAMP, calcium and IP3 are the second messengers commonly assessed to follow GPCR activation.
Drugs targeting GPCRs account for the majority of the best-selling drugs and about 40% of all prescription pharmaceuticals in the marketplace. An ever-growing interest in investigating GPCR targets in several therapeutic areas is expected, motivated by the desire to select a drug for new targets or a more selective drug targeting a specific pathway.
The assessment of cAMP with the homogeneous time-resolved fluorescence (HTRF) kits allows the implementation of functional assays to screen new drug candidates in high-throughput screening (HTS) conditions. Together with the IP-One kit for assessment of IP1, a downstream metabolite of IP3, Cisbio proposes a complete GPCR assay platform.
Here we describe the HTRF kits for cAMP detection.
Functional assays: cAMP accumulation
All Cisbio cAMP kits are based on a competitive immunoassay between native cAMP produced by cells and cAMP labeled with the acceptor dye d2. The two entities compete for binding to a cAMP-specific antibody labeled with cryptate (europium or terbium cryptate). The specific signal generated by fluorescence resonance energy transfer (FRET) is inversely proportional to the concentration of cAMP in the standard or sample (Fig. 1a) . cAMP kits to cover a broad range of assay conditions Cisbio offers four kits covering a broad range of working cAMP concentrations ( Table 1 ). The kits are intended for the direct, quantitative determination of cAMP and facilitate early, direct pharmacological characterization of compounds acting on G i -or G s -coupled receptors.
How to select a cAMP assay
In a cell-based assay, the intracellular cAMP level depends not only on the agonist or antagonist activity but also on the cellular model used. The technical criteria for evaluating the quality of an assay are the sensitivity, the assay signal-to-noise ratio, the working range (Fig. 1b) , the robustness (Z′ factors), the miniaturization and the number of steps.
In a cell-based assay, the cAMP produced within a well determines the working range of the assay, so several biological criteria The working range is defined as the cAMP concentration between 20 and 80% inhibitory concentration (IC 20 and IC 80 ). In this range, the signal variation is linearly proportional to the cAMP concentration.
coupled receptor stimulation requires a cAMP assay capable of discriminating a slight variation of cAMP concentration; that is, having a good signal-to-noise ratio. The pharmaceutical class of drug under investigation also has a bearing on the specifications required for the cAMP assay. For antagonism assays, sensitivity is often required to detect a slight variation of cAMP concentration ( Table 2) .
Conclusion
Because of the variability of the biological material and the pharmacological compounds acting on G i -or G s -coupled receptors, a selection of cAMP assay kits is necessary to cover a broad range of concentrations.
The homogeneous cAMP assay kits offered by Cisbio are compatible with robust (Z′ factors), miniaturized, high-throughput screens in either 384 or 1,536 wells. These cAMP accumulation assays have been applied to the investigation of G s -and G i -coupled GPCRs and can be used with recombinant, nonrecombinant or native receptors.
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APPLICATION NOTES
In the presence of an agonist, the cAMP level increases.
Antagonist Blocks receptor response by competing with agonists or inverse agonists.
In the presence of an antagonist, the effect of the agonist is inhibited, and the cAMP level increases. b
In the presence an agonist, the antagonist reduces the cAMP level. b
